3-D Matrix, Ltd.
3-D Matrix, Ltd. (DMTRF) Stock Competitors & Peer Comparison
See (DMTRF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DMTRF | $3.96 | +0.00% | 476M | -198.00 | -$0.02 | N/A |
| SEMHF | $39.53 | -1.06% | 45.4B | 18.27 | $2.22 | +3.01% |
| RYLPF | $27.25 | +1.20% | 25.9B | 23.29 | $1.17 | +3.49% |
| SMMNY | $19.86 | +0.08% | 22B | 17.73 | $1.11 | +3.01% |
| SONVY | $45.55 | -0.96% | 13.5B | 20.19 | $2.24 | +2.38% |
| SONVF | $224.67 | -3.30% | 13.4B | 20.10 | $11.18 | +2.41% |
| SNNUF | $14.95 | +0.00% | 12.8B | 20.76 | $0.72 | +2.63% |
| WILYY | $18.82 | +2.84% | 7.8B | 21.10 | $0.88 | N/A |
| WILLF | $34.10 | -4.16% | 7.2B | 19.38 | $1.76 | N/A |
| GNGBF | $23.23 | +0.00% | 5.9B | 25.25 | $0.92 | +2.22% |
Stock Comparison
DMTRF vs SEMHF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, SEMHF has a market cap of 45.4B. Regarding current trading prices, DMTRF is priced at $3.96, while SEMHF trades at $39.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas SEMHF's P/E ratio is 18.27. In terms of profitability, DMTRF's ROE is +0.36%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, DMTRF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SEMHF's competition here
DMTRF vs RYLPF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, RYLPF has a market cap of 25.9B. Regarding current trading prices, DMTRF is priced at $3.96, while RYLPF trades at $27.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas RYLPF's P/E ratio is 23.29. In terms of profitability, DMTRF's ROE is +0.36%, compared to RYLPF's ROE of +0.09%. Regarding short-term risk, DMTRF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check RYLPF's competition here
DMTRF vs SMMNY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, SMMNY has a market cap of 22B. Regarding current trading prices, DMTRF is priced at $3.96, while SMMNY trades at $19.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas SMMNY's P/E ratio is 17.73. In terms of profitability, DMTRF's ROE is +0.36%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, DMTRF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SMMNY's competition here
DMTRF vs SONVY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, SONVY has a market cap of 13.5B. Regarding current trading prices, DMTRF is priced at $3.96, while SONVY trades at $45.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas SONVY's P/E ratio is 20.19. In terms of profitability, DMTRF's ROE is +0.36%, compared to SONVY's ROE of +0.20%. Regarding short-term risk, DMTRF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SONVY's competition here
DMTRF vs SONVF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, SONVF has a market cap of 13.4B. Regarding current trading prices, DMTRF is priced at $3.96, while SONVF trades at $224.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas SONVF's P/E ratio is 20.10. In terms of profitability, DMTRF's ROE is +0.36%, compared to SONVF's ROE of +0.20%. Regarding short-term risk, DMTRF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SONVF's competition here
DMTRF vs SNNUF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, SNNUF has a market cap of 12.8B. Regarding current trading prices, DMTRF is priced at $3.96, while SNNUF trades at $14.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas SNNUF's P/E ratio is 20.76. In terms of profitability, DMTRF's ROE is +0.36%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, DMTRF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SNNUF's competition here
DMTRF vs WILYY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, WILYY has a market cap of 7.8B. Regarding current trading prices, DMTRF is priced at $3.96, while WILYY trades at $18.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas WILYY's P/E ratio is 21.10. In terms of profitability, DMTRF's ROE is +0.36%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, DMTRF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check WILYY's competition here
DMTRF vs WILLF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, WILLF has a market cap of 7.2B. Regarding current trading prices, DMTRF is priced at $3.96, while WILLF trades at $34.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas WILLF's P/E ratio is 19.38. In terms of profitability, DMTRF's ROE is +0.36%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, DMTRF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check WILLF's competition here
DMTRF vs GNGBF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, GNGBF has a market cap of 5.9B. Regarding current trading prices, DMTRF is priced at $3.96, while GNGBF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas GNGBF's P/E ratio is 25.25. In terms of profitability, DMTRF's ROE is +0.36%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check GNGBF's competition here
DMTRF vs GNGBY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, GNGBY has a market cap of 5.7B. Regarding current trading prices, DMTRF is priced at $3.96, while GNGBY trades at $20.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas GNGBY's P/E ratio is 22.18. In terms of profitability, DMTRF's ROE is +0.36%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check GNGBY's competition here
DMTRF vs CHEOF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, CHEOF has a market cap of 4.8B. Regarding current trading prices, DMTRF is priced at $3.96, while CHEOF trades at $73.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas CHEOF's P/E ratio is 19.30. In terms of profitability, DMTRF's ROE is +0.36%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, DMTRF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CHEOF's competition here
DMTRF vs CHEOY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, CHEOY has a market cap of 4.8B. Regarding current trading prices, DMTRF is priced at $3.96, while CHEOY trades at $36.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas CHEOY's P/E ratio is 19.19. In terms of profitability, DMTRF's ROE is +0.36%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, DMTRF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CHEOY's competition here
DMTRF vs AMBFF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, AMBFF has a market cap of 3.4B. Regarding current trading prices, DMTRF is priced at $3.96, while AMBFF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas AMBFF's P/E ratio is 46.43. In terms of profitability, DMTRF's ROE is +0.36%, compared to AMBFF's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check AMBFF's competition here
DMTRF vs NHNKY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, NHNKY has a market cap of 3B. Regarding current trading prices, DMTRF is priced at $3.96, while NHNKY trades at $9.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas NHNKY's P/E ratio is 13.24. In terms of profitability, DMTRF's ROE is +0.36%, compared to NHNKY's ROE of +0.07%. Regarding short-term risk, DMTRF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check NHNKY's competition here
DMTRF vs AMBBY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, AMBBY has a market cap of 2.6B. Regarding current trading prices, DMTRF is priced at $3.96, while AMBBY trades at $9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas AMBBY's P/E ratio is 34.91. In terms of profitability, DMTRF's ROE is +0.36%, compared to AMBBY's ROE of +0.08%. Regarding short-term risk, DMTRF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check AMBBY's competition here
DMTRF vs GNNDY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, GNNDY has a market cap of 2.2B. Regarding current trading prices, DMTRF is priced at $3.96, while GNNDY trades at $45.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas GNNDY's P/E ratio is 53.86. In terms of profitability, DMTRF's ROE is +0.36%, compared to GNNDY's ROE of -0.04%. Regarding short-term risk, DMTRF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check GNNDY's competition here
DMTRF vs OSSFF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, DMTRF is priced at $3.96, while OSSFF trades at $5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas OSSFF's P/E ratio is 25.55. In terms of profitability, DMTRF's ROE is +0.36%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check OSSFF's competition here
DMTRF vs MCRPF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, MCRPF has a market cap of 2.2B. Regarding current trading prices, DMTRF is priced at $3.96, while MCRPF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas MCRPF's P/E ratio is -12.67. In terms of profitability, DMTRF's ROE is +0.36%, compared to MCRPF's ROE of +0.06%. Regarding short-term risk, DMTRF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check MCRPF's competition here
DMTRF vs DRWKF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, DMTRF is priced at $3.96, while DRWKF trades at $111.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas DRWKF's P/E ratio is 11.67. In terms of profitability, DMTRF's ROE is +0.36%, compared to DRWKF's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check DRWKF's competition here
DMTRF vs GGNDF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, DMTRF is priced at $3.96, while GGNDF trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas GGNDF's P/E ratio is 50.39. In terms of profitability, DMTRF's ROE is +0.36%, compared to GGNDF's ROE of -0.04%. Regarding short-term risk, DMTRF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check GGNDF's competition here
DMTRF vs DWRKF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, DMTRF is priced at $3.96, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, DMTRF's ROE is +0.36%, compared to DWRKF's ROE of N/A. Regarding short-term risk, DMTRF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check DWRKF's competition here
DMTRF vs NHNKF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, NHNKF has a market cap of 1.7B. Regarding current trading prices, DMTRF is priced at $3.96, while NHNKF trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas NHNKF's P/E ratio is 30.28. In terms of profitability, DMTRF's ROE is +0.36%, compared to NHNKF's ROE of +0.07%. Regarding short-term risk, DMTRF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check NHNKF's competition here
DMTRF vs OSSUY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, DMTRF is priced at $3.96, while OSSUY trades at $4.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas OSSUY's P/E ratio is 20.05. In terms of profitability, DMTRF's ROE is +0.36%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check OSSUY's competition here
DMTRF vs STSEY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, STSEY has a market cap of 1.7B. Regarding current trading prices, DMTRF is priced at $3.96, while STSEY trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas STSEY's P/E ratio is 18.37. In terms of profitability, DMTRF's ROE is +0.36%, compared to STSEY's ROE of -0.00%. Regarding short-term risk, DMTRF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check STSEY's competition here
DMTRF vs MEDGF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, DMTRF is priced at $3.96, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, DMTRF's ROE is +0.36%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, DMTRF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check MEDGF's competition here
DMTRF vs FDMDF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, FDMDF has a market cap of 1.7B. Regarding current trading prices, DMTRF is priced at $3.96, while FDMDF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas FDMDF's P/E ratio is -9.66. In terms of profitability, DMTRF's ROE is +0.36%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, DMTRF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check FDMDF's competition here
DMTRF vs VTRLY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, DMTRF is priced at $3.96, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas VTRLY's P/E ratio is -2.75. In terms of profitability, DMTRF's ROE is +0.36%, compared to VTRLY's ROE of -0.47%. Regarding short-term risk, DMTRF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check VTRLY's competition here
DMTRF vs MDRSF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, DMTRF is priced at $3.96, while MDRSF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas MDRSF's P/E ratio is 133.72. In terms of profitability, DMTRF's ROE is +0.36%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, DMTRF is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check MDRSF's competition here
DMTRF vs DGWPF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, DGWPF has a market cap of 1.4B. Regarding current trading prices, DMTRF is priced at $3.96, while DGWPF trades at $72.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas DGWPF's P/E ratio is 7.53. In terms of profitability, DMTRF's ROE is +0.36%, compared to DGWPF's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check DGWPF's competition here
DMTRF vs LFTSF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, DMTRF is priced at $3.96, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, DMTRF's ROE is +0.36%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, DMTRF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check LFTSF's competition here
DMTRF vs ELEAF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, ELEAF has a market cap of 759.8M. Regarding current trading prices, DMTRF is priced at $3.96, while ELEAF trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas ELEAF's P/E ratio is 12.99. In terms of profitability, DMTRF's ROE is +0.36%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, DMTRF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ELEAF's competition here
DMTRF vs XVIPF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, XVIPF has a market cap of 603.2M. Regarding current trading prices, DMTRF is priced at $3.96, while XVIPF trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas XVIPF's P/E ratio is 76.60. In terms of profitability, DMTRF's ROE is +0.36%, compared to XVIPF's ROE of +0.03%. Regarding short-term risk, DMTRF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check XVIPF's competition here
DMTRF vs BRSYF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, BRSYF has a market cap of 542.4M. Regarding current trading prices, DMTRF is priced at $3.96, while BRSYF trades at $13.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas BRSYF's P/E ratio is 75.28. In terms of profitability, DMTRF's ROE is +0.36%, compared to BRSYF's ROE of +0.11%. Regarding short-term risk, DMTRF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check BRSYF's competition here
DMTRF vs CALZF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, CALZF has a market cap of 514.1M. Regarding current trading prices, DMTRF is priced at $3.96, while CALZF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas CALZF's P/E ratio is 74.41. In terms of profitability, DMTRF's ROE is +0.36%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, DMTRF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CALZF's competition here
DMTRF vs IOBCF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, IOBCF has a market cap of 501.5M. Regarding current trading prices, DMTRF is priced at $3.96, while IOBCF trades at $17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas IOBCF's P/E ratio is 34.90. In terms of profitability, DMTRF's ROE is +0.36%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check IOBCF's competition here
DMTRF vs AVMR Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, DMTRF is priced at $3.96, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas AVMR's P/E ratio is -18.34. In terms of profitability, DMTRF's ROE is +0.36%, compared to AVMR's ROE of -0.30%. Regarding short-term risk, DMTRF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check AVMR's competition here
DMTRF vs HYBT Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, DMTRF is priced at $3.96, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas HYBT's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is +0.36%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, DMTRF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check HYBT's competition here
DMTRF vs CLVSF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, CLVSF has a market cap of 321.8M. Regarding current trading prices, DMTRF is priced at $3.96, while CLVSF trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas CLVSF's P/E ratio is 22.11. In terms of profitability, DMTRF's ROE is +0.36%, compared to CLVSF's ROE of +0.15%. Regarding short-term risk, DMTRF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CLVSF's competition here
DMTRF vs CYBQY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, CYBQY has a market cap of 303.2M. Regarding current trading prices, DMTRF is priced at $3.96, while CYBQY trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas CYBQY's P/E ratio is -170.00. In terms of profitability, DMTRF's ROE is +0.36%, compared to CYBQY's ROE of -0.00%. Regarding short-term risk, DMTRF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CYBQY's competition here
DMTRF vs CSSPF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, CSSPF has a market cap of 273.5M. Regarding current trading prices, DMTRF is priced at $3.96, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas CSSPF's P/E ratio is 32.50. In terms of profitability, DMTRF's ROE is +0.36%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, DMTRF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CSSPF's competition here
DMTRF vs HTLZF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, DMTRF is priced at $3.96, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, DMTRF's ROE is +0.36%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, DMTRF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check HTLZF's competition here
DMTRF vs IMPZY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, IMPZY has a market cap of 229.3M. Regarding current trading prices, DMTRF is priced at $3.96, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, DMTRF's ROE is +0.36%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, DMTRF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check IMPZY's competition here
DMTRF vs CYBQF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, CYBQF has a market cap of 206.8M. Regarding current trading prices, DMTRF is priced at $3.96, while CYBQF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas CYBQF's P/E ratio is -155.00. In terms of profitability, DMTRF's ROE is +0.36%, compared to CYBQF's ROE of -0.00%. Regarding short-term risk, DMTRF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CYBQF's competition here
DMTRF vs VMTHF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, DMTRF is priced at $3.96, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, DMTRF's ROE is +0.36%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, DMTRF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check VMTHF's competition here
DMTRF vs BCCOY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, BCCOY has a market cap of 183.5M. Regarding current trading prices, DMTRF is priced at $3.96, while BCCOY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas BCCOY's P/E ratio is -1.14. In terms of profitability, DMTRF's ROE is +0.36%, compared to BCCOY's ROE of -0.51%. Regarding short-term risk, DMTRF is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check BCCOY's competition here
DMTRF vs DTXMF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, DMTRF is priced at $3.96, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, DMTRF's ROE is +0.36%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, DMTRF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check DTXMF's competition here
DMTRF vs EKDHF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, EKDHF has a market cap of 167.9M. Regarding current trading prices, DMTRF is priced at $3.96, while EKDHF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas EKDHF's P/E ratio is 39.00. In terms of profitability, DMTRF's ROE is +0.36%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, DMTRF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check EKDHF's competition here
DMTRF vs EAPIF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, EAPIF has a market cap of 162.8M. Regarding current trading prices, DMTRF is priced at $3.96, while EAPIF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas EAPIF's P/E ratio is -0.65. In terms of profitability, DMTRF's ROE is +0.36%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, DMTRF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check EAPIF's competition here
DMTRF vs BRNHF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, BRNHF has a market cap of 161.7M. Regarding current trading prices, DMTRF is priced at $3.96, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, DMTRF's ROE is +0.36%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, DMTRF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check BRNHF's competition here
DMTRF vs CLLKF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, CLLKF has a market cap of 136.8M. Regarding current trading prices, DMTRF is priced at $3.96, while CLLKF trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas CLLKF's P/E ratio is -0.88. In terms of profitability, DMTRF's ROE is +0.36%, compared to CLLKF's ROE of -0.52%. Regarding short-term risk, DMTRF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CLLKF's competition here
DMTRF vs AMEUF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, DMTRF is priced at $3.96, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, DMTRF's ROE is +0.36%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, DMTRF is more volatile compared to AMEUF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check AMEUF's competition here
DMTRF vs PXMBF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, PXMBF has a market cap of 119.9M. Regarding current trading prices, DMTRF is priced at $3.96, while PXMBF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, DMTRF's ROE is +0.36%, compared to PXMBF's ROE of -0.04%. Regarding short-term risk, DMTRF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check PXMBF's competition here
DMTRF vs SNZZF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, SNZZF has a market cap of 110.1M. Regarding current trading prices, DMTRF is priced at $3.96, while SNZZF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas SNZZF's P/E ratio is -7.78. In terms of profitability, DMTRF's ROE is +0.36%, compared to SNZZF's ROE of -0.38%. Regarding short-term risk, DMTRF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SNZZF's competition here
DMTRF vs AVHHL Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, AVHHL has a market cap of 102.7M. Regarding current trading prices, DMTRF is priced at $3.96, while AVHHL trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas AVHHL's P/E ratio is -2.36. In terms of profitability, DMTRF's ROE is +0.36%, compared to AVHHL's ROE of +4.77%. Regarding short-term risk, DMTRF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check AVHHL's competition here
DMTRF vs SOMNF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, SOMNF has a market cap of 98.6M. Regarding current trading prices, DMTRF is priced at $3.96, while SOMNF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas SOMNF's P/E ratio is -45.00. In terms of profitability, DMTRF's ROE is +0.36%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, DMTRF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check SOMNF's competition here
DMTRF vs JMDMF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, JMDMF has a market cap of 94.1M. Regarding current trading prices, DMTRF is priced at $3.96, while JMDMF trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas JMDMF's P/E ratio is -13.68. In terms of profitability, DMTRF's ROE is +0.36%, compared to JMDMF's ROE of N/A. Regarding short-term risk, DMTRF is more volatile compared to JMDMF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check JMDMF's competition here
DMTRF vs RSHUF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, DMTRF is priced at $3.96, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, DMTRF's ROE is +0.36%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, DMTRF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check RSHUF's competition here
DMTRF vs CKMTF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, DMTRF is priced at $3.96, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, DMTRF's ROE is +0.36%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, DMTRF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CKMTF's competition here
DMTRF vs BLOZF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, BLOZF has a market cap of 64.7M. Regarding current trading prices, DMTRF is priced at $3.96, while BLOZF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas BLOZF's P/E ratio is -13.20. In terms of profitability, DMTRF's ROE is +0.36%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, DMTRF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check BLOZF's competition here
DMTRF vs TLTFF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, TLTFF has a market cap of 54.9M. Regarding current trading prices, DMTRF is priced at $3.96, while TLTFF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas TLTFF's P/E ratio is -19.90. In terms of profitability, DMTRF's ROE is +0.36%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, DMTRF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check TLTFF's competition here
DMTRF vs NVYTF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, DMTRF is priced at $3.96, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, DMTRF's ROE is +0.36%, compared to NVYTF's ROE of -1.25%. Regarding short-term risk, DMTRF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check NVYTF's competition here
DMTRF vs RDGL Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, RDGL has a market cap of 29.9M. Regarding current trading prices, DMTRF is priced at $3.96, while RDGL trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas RDGL's P/E ratio is -6.20. In terms of profitability, DMTRF's ROE is +0.36%, compared to RDGL's ROE of -1.26%. Regarding short-term risk, DMTRF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check RDGL's competition here
DMTRF vs POSC Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, POSC has a market cap of 26.1M. Regarding current trading prices, DMTRF is priced at $3.96, while POSC trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas POSC's P/E ratio is -5.38. In terms of profitability, DMTRF's ROE is +0.36%, compared to POSC's ROE of -4.69%. Regarding short-term risk, DMTRF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check POSC's competition here
DMTRF vs MKEAF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, DMTRF is priced at $3.96, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, DMTRF's ROE is +0.36%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, DMTRF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check MKEAF's competition here
DMTRF vs TCLIF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, DMTRF is priced at $3.96, while TCLIF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas TCLIF's P/E ratio is -4.84. In terms of profitability, DMTRF's ROE is +0.36%, compared to TCLIF's ROE of +2.39%. Regarding short-term risk, DMTRF is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check TCLIF's competition here
DMTRF vs PYNKF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, PYNKF has a market cap of 24.9M. Regarding current trading prices, DMTRF is priced at $3.96, while PYNKF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas PYNKF's P/E ratio is 3.96. In terms of profitability, DMTRF's ROE is +0.36%, compared to PYNKF's ROE of -2.78%. Regarding short-term risk, DMTRF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check PYNKF's competition here
DMTRF vs KBBTF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, DMTRF is priced at $3.96, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, DMTRF's ROE is +0.36%, compared to KBBTF's ROE of N/A. Regarding short-term risk, DMTRF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check KBBTF's competition here
DMTRF vs EMITF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, EMITF has a market cap of 21.3M. Regarding current trading prices, DMTRF is priced at $3.96, while EMITF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas EMITF's P/E ratio is -7.62. In terms of profitability, DMTRF's ROE is +0.36%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, DMTRF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check EMITF's competition here
DMTRF vs VPTDF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, VPTDF has a market cap of 18.5M. Regarding current trading prices, DMTRF is priced at $3.96, while VPTDF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas VPTDF's P/E ratio is -4.94. In terms of profitability, DMTRF's ROE is +0.36%, compared to VPTDF's ROE of +0.78%. Regarding short-term risk, DMTRF is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check VPTDF's competition here
DMTRF vs DIZTF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, DMTRF is priced at $3.96, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, DMTRF's ROE is +0.36%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, DMTRF is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check DIZTF's competition here
DMTRF vs GTHP Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, GTHP has a market cap of 16.9M. Regarding current trading prices, DMTRF is priced at $3.96, while GTHP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas GTHP's P/E ratio is -5.50. In terms of profitability, DMTRF's ROE is +0.36%, compared to GTHP's ROE of +0.82%. Regarding short-term risk, DMTRF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check GTHP's competition here
DMTRF vs IPDQF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, IPDQF has a market cap of 16.3M. Regarding current trading prices, DMTRF is priced at $3.96, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas IPDQF's P/E ratio is -0.80. In terms of profitability, DMTRF's ROE is +0.36%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, DMTRF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check IPDQF's competition here
DMTRF vs MDXHF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, DMTRF is priced at $3.96, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, DMTRF's ROE is +0.36%, compared to MDXHF's ROE of +0.66%. Regarding short-term risk, DMTRF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check MDXHF's competition here
DMTRF vs ASAPF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, ASAPF has a market cap of 14.1M. Regarding current trading prices, DMTRF is priced at $3.96, while ASAPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas ASAPF's P/E ratio is -18.12. In terms of profitability, DMTRF's ROE is +0.36%, compared to ASAPF's ROE of -0.19%. Regarding short-term risk, DMTRF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ASAPF's competition here
DMTRF vs TMDIF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, DMTRF is priced at $3.96, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, DMTRF's ROE is +0.36%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, DMTRF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check TMDIF's competition here
DMTRF vs ATBPF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, DMTRF is priced at $3.96, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, DMTRF's ROE is +0.36%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, DMTRF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ATBPF's competition here
DMTRF vs LXXGF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, DMTRF is priced at $3.96, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, DMTRF's ROE is +0.36%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, DMTRF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check LXXGF's competition here
DMTRF vs ALRTF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, ALRTF has a market cap of 9.7M. Regarding current trading prices, DMTRF is priced at $3.96, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas ALRTF's P/E ratio is -0.38. In terms of profitability, DMTRF's ROE is +0.36%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, DMTRF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ALRTF's competition here
DMTRF vs PLLWF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, DMTRF is priced at $3.96, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, DMTRF's ROE is +0.36%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, DMTRF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check PLLWF's competition here
DMTRF vs PMEDF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, PMEDF has a market cap of 7.3M. Regarding current trading prices, DMTRF is priced at $3.96, while PMEDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas PMEDF's P/E ratio is -3.53. In terms of profitability, DMTRF's ROE is +0.36%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, DMTRF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check PMEDF's competition here
DMTRF vs BIEL Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, BIEL has a market cap of 7.2M. Regarding current trading prices, DMTRF is priced at $3.96, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas BIEL's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is +0.36%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, DMTRF is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check BIEL's competition here
DMTRF vs USAQ Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, USAQ has a market cap of 6.3M. Regarding current trading prices, DMTRF is priced at $3.96, while USAQ trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas USAQ's P/E ratio is 28.02. In terms of profitability, DMTRF's ROE is +0.36%, compared to USAQ's ROE of -8.25%. Regarding short-term risk, DMTRF is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check USAQ's competition here
DMTRF vs RMSL Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, RMSL has a market cap of 5.7M. Regarding current trading prices, DMTRF is priced at $3.96, while RMSL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas RMSL's P/E ratio is 0.34. In terms of profitability, DMTRF's ROE is +0.36%, compared to RMSL's ROE of -17961324.55%. Regarding short-term risk, DMTRF is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check RMSL's competition here
DMTRF vs ADMT Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, ADMT has a market cap of 5.6M. Regarding current trading prices, DMTRF is priced at $3.96, while ADMT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas ADMT's P/E ratio is -8.35. In terms of profitability, DMTRF's ROE is +0.36%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, DMTRF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ADMT's competition here
DMTRF vs QLIS Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, DMTRF is priced at $3.96, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas QLIS's P/E ratio is 2.22. In terms of profitability, DMTRF's ROE is +0.36%, compared to QLIS's ROE of -0.77%. Regarding short-term risk, DMTRF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check QLIS's competition here
DMTRF vs RHNMF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, DMTRF is priced at $3.96, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, DMTRF's ROE is +0.36%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, DMTRF is more volatile compared to RHNMF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check RHNMF's competition here
DMTRF vs ODYY Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, ODYY has a market cap of 5M. Regarding current trading prices, DMTRF is priced at $3.96, while ODYY trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas ODYY's P/E ratio is -1.00. In terms of profitability, DMTRF's ROE is +0.36%, compared to ODYY's ROE of +0.58%. Regarding short-term risk, DMTRF is more volatile compared to ODYY. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ODYY's competition here
DMTRF vs VANIW Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, DMTRF is priced at $3.96, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas VANIW's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is +0.36%, compared to VANIW's ROE of -3.17%. Regarding short-term risk, DMTRF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for DMTRF.Check VANIW's competition here
DMTRF vs CYDX Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, CYDX has a market cap of 3.2M. Regarding current trading prices, DMTRF is priced at $3.96, while CYDX trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas CYDX's P/E ratio is 0.79. In terms of profitability, DMTRF's ROE is +0.36%, compared to CYDX's ROE of +0.13%. Regarding short-term risk, DMTRF is more volatile compared to CYDX. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check CYDX's competition here
DMTRF vs LLBO Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, LLBO has a market cap of 3M. Regarding current trading prices, DMTRF is priced at $3.96, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas LLBO's P/E ratio is N/A. In terms of profitability, DMTRF's ROE is +0.36%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, DMTRF is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check LLBO's competition here
DMTRF vs TBRIF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, TBRIF has a market cap of 2.8M. Regarding current trading prices, DMTRF is priced at $3.96, while TBRIF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas TBRIF's P/E ratio is -0.96. In terms of profitability, DMTRF's ROE is +0.36%, compared to TBRIF's ROE of +2.92%. Regarding short-term risk, DMTRF is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check TBRIF's competition here
DMTRF vs NGMDF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, NGMDF has a market cap of 2.4M. Regarding current trading prices, DMTRF is priced at $3.96, while NGMDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas NGMDF's P/E ratio is -1.04. In terms of profitability, DMTRF's ROE is +0.36%, compared to NGMDF's ROE of +0.94%. Regarding short-term risk, DMTRF is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check NGMDF's competition here
DMTRF vs VYCO Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, VYCO has a market cap of 2.3M. Regarding current trading prices, DMTRF is priced at $3.96, while VYCO trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas VYCO's P/E ratio is -7.00. In terms of profitability, DMTRF's ROE is +0.36%, compared to VYCO's ROE of +0.02%. Regarding short-term risk, DMTRF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check VYCO's competition here
DMTRF vs KLYG Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, KLYG has a market cap of 2.2M. Regarding current trading prices, DMTRF is priced at $3.96, while KLYG trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas KLYG's P/E ratio is -17.68. In terms of profitability, DMTRF's ROE is +0.36%, compared to KLYG's ROE of -0.19%. Regarding short-term risk, DMTRF is more volatile compared to KLYG. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check KLYG's competition here
DMTRF vs FZMD Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, FZMD has a market cap of 2M. Regarding current trading prices, DMTRF is priced at $3.96, while FZMD trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas FZMD's P/E ratio is 1.35. In terms of profitability, DMTRF's ROE is +0.36%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, DMTRF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check FZMD's competition here
DMTRF vs NUMD Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, NUMD has a market cap of 1.5M. Regarding current trading prices, DMTRF is priced at $3.96, while NUMD trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas NUMD's P/E ratio is 1.74. In terms of profitability, DMTRF's ROE is +0.36%, compared to NUMD's ROE of +0.22%. Regarding short-term risk, DMTRF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check NUMD's competition here
DMTRF vs ESMC Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, ESMC has a market cap of 1.3M. Regarding current trading prices, DMTRF is priced at $3.96, while ESMC trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas ESMC's P/E ratio is -5.67. In terms of profitability, DMTRF's ROE is +0.36%, compared to ESMC's ROE of -125.28%. Regarding short-term risk, DMTRF is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ESMC's competition here
DMTRF vs UAHC Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, UAHC has a market cap of 777.5K. Regarding current trading prices, DMTRF is priced at $3.96, while UAHC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas UAHC's P/E ratio is 0.56. In terms of profitability, DMTRF's ROE is +0.36%, compared to UAHC's ROE of +0.04%. Regarding short-term risk, DMTRF is more volatile compared to UAHC. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check UAHC's competition here
DMTRF vs ELXMF Comparison May 2026
DMTRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DMTRF stands at 476M. In comparison, ELXMF has a market cap of 541.2K. Regarding current trading prices, DMTRF is priced at $3.96, while ELXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DMTRF currently has a P/E ratio of -198.00, whereas ELXMF's P/E ratio is -0.09. In terms of profitability, DMTRF's ROE is +0.36%, compared to ELXMF's ROE of -0.40%. Regarding short-term risk, DMTRF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for DMTRF.Check ELXMF's competition here